Survey on centres and procedures for the diagnosis and treatment of adult ADHD in public services in Italy.

Attention deficit/hyperactivity disorder (ADHD) often persists into adulthood. Although its persistence and relative high prevalence, ADHD in adults is often underdiagnosed and undertreated in Italy, leading to poor clinical and functional outcomes, and higher costs of illness. The aims of the study were to identify the Italian mental health services for ADHD in adults, describe the diagnostic and treatment procedures they follow, and compare this offer with the recommendations of the German and English guidelines. The centres, that adopt a clinical and assessment protocol for adult ADHD diagnosis (carried out by specifically trained personnel) and prescribe pharmacological treatment for adult ADHD, were selected from the list of accredited services provided by the Appendix B.2 of the ISTISAN 16/37 Reports of the ISS. An ad-hoc survey including open-ended and close-ended questions was sent to each selected centre in February 2020. The overall picture resulting from the data analysis was compared with the recommendations of the German and English guidelines. The present survey shows that only a few centres are specialised in the diagnosis and treatment of ADHD in adults in Italy. Furthermore, there are no national guidelines for adult ADHD in Italy. The collected data also suggest that there is no a unified practice shared by the Centres both for the patient's transition from child and adolescent to adult mental health services and for the diagnostic-therapeutic process. It is therefore crucial to create specific protocols and develop national guidelines to better identify and diagnose ADHD in adults and provide targeted and more efficient multimodal treatments.

[Psychopharmacological treatment: patients' knowledge about their medication]. / Conoscenza del trattamento farmacologico da parte di pazienti con disturbi psichici.

AIMS: To identify knowledge about medication in a sample of patients admitted in a residential psychiatric rehabilitation unit. METHODS: All consecutive patients admitted in a psychiatric rehabilitation unit during January 2000-April 2001 were interviewed about the medications prescribed; in particular they were asked about names, daily dose, therapeutic and side effects of the psychotropic drugs they took. RESULTS: 74 patients were surveyed about their knowledge of the psychopharmacological treatment they took. Most patients demonstrated a good knowledge about drugs' name (77%) and daily dose (74.3%); one-quarter (25.7%) had some understanding about the reason why the medications were prescribed and theirs intended effects while only 5.4% was able to indicate the side effects of medications prescribed. Overall, 21.6% of patients could correctly indicate drugs' name, daily dose and therapeutic effects of all medications they took. CONCLUSIONS: The results of our study indicate the importance in clinical practice to devote particular attention to the patients' understanding of provided information about treatment and the crucial role of strategies, aimed at improving compliance and maximize the effects of therapeutic interventions.